| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia. | Wanitpongpun, C Teawtrakul, N Mahakkanukrauh, A Siritunyaporn, S Sirijerachai, C Chansung, K |
0 | ||||
| 2. | Discontinuation of Antimalarial in Systemic Lupus Erythematosus | Ajanee Mahakkanukrauh | 1999 | ||||
| 3. | Long term treatment outcome of Salmonella septic arthritis. | R Nanagara S Suwannaroj A Mahakkanukrauh HR Schumacher |
2001 | ||||
| 4. | Quinolones and Salmonella septic arthritis | Mootsikapun, P Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2002 | ||||
| 5. | Exertional rhabdomyolysis following excessive exercise of university freshman cheer-training. | Mahakkanukrauh, A. Sangchan, A. Mootsikapun, P. |
2003 | ||||
| 6. | Tuberculous pyomyositis. | Mootsikapun, P. Suwannaroj, S. Mahakkanukrauh, A. Nanagara, R. |
2003 | ||||
| 7. | Systemic sclerosis (SSC) in the northeastern Thais: A clinical data in 506 patients | S Suwannaroj A Mahakkanukrauh R Nanagara |
2004 | ||||
| 8. | Outward migration of Gnathostoma spinigerum in interferon alpha treated hepatitis C patient | Sangchan, A. Sawanyawisuth, K. Intapan, P.M.A. Mahakkanukrauh, A. |
2006 | ||||
| 9. | Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital. | Foocharoen, C. Nanagara, R. Salang, L. Suwannaroj, S. Mahakkanukrauh, A. |
2009 | ||||
| 10. | Clinical features of tuberculous septic arthritis in Khon Kaen, Thailand: a 10-year retrospective study. | Foocharoen, C. Nanagara, R. Suwannaroj, S. Mahakkanukrauh, A. |
2010 | ||||
| 11. | Clinical features and disease outcomes of undifferentiated arthritis in Thailand | Chingching Foocharoen Ratanavadee Nanagara Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2011 | ||||
| 12. | Erratum: Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients (Clin Rheumatol (2011) 30 (1263) DOI 10.1007/s10067-011-1744-z) | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2011 | ||||
| 13. | Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand | Chingching Foocharoen Ratanavadee Nanagara Songsak Kiatchoosakun Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2011 | ||||
| 14. | Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2011 | ||||
| 15. | Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment | Chingching Foocharoen Ratanavadee Nanagara Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2011 | ||||
| 16. | SYNOVIAL FLUID ADENOSINE DEAMINASE ACTIVITY TO DIAGNOSE TUBERCULOUS SEPTIC ARTHRITIS | Foocharoen, C. Mahakkanukrauh, A. Paupairoj, A. Teerajetgul, Y. Nanagara, R. |
2011 | ||||
| 17. | Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia | C. Wanitpongpun N. Teawtrakul A. Mahakkanukrauh S. Siritunyaporn C. Sirijerachai K. Chansung |
2012 | ||||
| 18. | INCIDENCE RATE AND CAUSES OF INFECTION IN THAI SSc PATIENTS | C. Foocharoen Y. Siriphanon A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 | ||||
| 19. | Incidence rate and causes of infection in Thai systemic sclerosis patients. | Chingching Foocharoen Yada Siriphannon Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2012 | ||||
| 20. | PATTERN OF SKIN THICKNESS PROGRESSION AND CLINICAL CORRELATION IN THAI SCLERODERMA PATIENTS | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 | ||||
| 21. | Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients | Kunyakham, W Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 | ||||
| 22. | PROGNOSTIC FACTORS OF MORTALITY AND 2-YEAR SURVIVAL ANALYSIS OF SSc WITH PULMONARY ARTERIAL HYPERTENSION IN THAILAND | C. Foocharoen R. Nanagara S. Kiatchoosakun S. Suwannaroj A. Mahakkanukrauh |
2012 | ||||
| 23. | SPONTANEOUS SKIN REGRESSION AND PREDICTORS OF SKIN REGRESSION IN THAI SCLERODERMA PATIENTS | C. Foocharoen A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 | ||||
| 24. | Admission rate and characteristics of hospitalized systemic connective tissue disorders: Analysis from a nationwide Thailand healthcare database | Foocharoen, C Thavornpitak, Y Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2013 | ||||
| 25. | Adverse Drug Reactions Monitoring to Disease Modifying Antirheumatic Drugs (DMARDs) by Patient Self Reports | Pichayanin Ongtrakoolaree Narumol Jarernsiripornkul Ausanee Uajariyaku Ajanee Mahakkanukrauh |
2013 | ||||
| 26. | Features and outcomes of hospitalized Thai patients with pyogenic arthritis: Analysis from the nationwide hospital database | Mahakkanukrauh, A. Thavornpitak, Y. Foocharoen, C. Suwannaroj, S. Nanagara, R. |
2013 | ||||
| 27. | Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis | Netwijitpan, S Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2013 | ||||
| 28. | Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2013 | ||||
| 29. | ASYMPTOMATIC CARDIAC INVOLVEMENT IN THAI SYSTEMIC SCLEROSIS: PREVALENCE AND CLINICAL CORRELATION | C. Foocharoen B. Pussadhamma A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2014 | ||||
| 30. | Clinical characteristics and mortality in systemic sclerosis: A comparison between early- and late-referred diseases | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2014 | ||||
| 31. | Incidence of Pulmonary Hypertension in Patients With Systemic Sclerosis and No Pulmonary Symptoms: Is Annual Echocardiographic Screening Necessary? | Foocharoen, C Mahakkanukrauh, A Pussadhamma, B Netwijitpan, S Suwannaroj, S Nanagara, R |
2014 | ||||
| 32. | Prevalence and causes of loss to follow-up among patients with systemic sclerosis | Chingching Foocharoen Patinut Yenrom Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2014 | ||||
| 33. | Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). | Chingching Foocharoen Burabha Pussadhamma Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2015 | ||||
| 34. | Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis | Pichaporn Sumphao-Ngern Chingching Foocharoen Watchara Boonsawat Ajanee Mahakkanukrauh Siraphop Suwannaroj Uraiwan Sae-Oue Sittichai Netwijitpan Ratanavadee Nanagara |
2015 | ||||
| 35. | Drug Survival and Reasons for Discontinuation of Biological Disease Modifying Antirheumatic Drug in Thai Patients with Rheumatoid Arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization (RDPA) Register | Pongthorn Narongroeknawin Wanruchada Katchamart Parawee Suwannalai Nuntana Kasitanon Tasanee Kitumnuaypong Ajanee Mahakkanukrauh Boonjing Siripaitoon |
2015 | ||||
| 36. | Inter-and intra-observer reliability of modified rodnan skin score assessment in Thai systemic sclerosis patients: A validation for multicenter scleroderma cohort study | Foocharoen, C. Thinkhamrop, B. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Towiwat, P. Nanagara, R. |
2015 | ||||
| 37. | The Association of HLA and Systemic Sclerosis (SSc) in the Northeastern Thais. | Ajanee Mahakkanukrauh Siraphob Suwannaroj Amornrat Romphruk Chintana Puapairoj Arunrat Romphruk Chanvit Leelayuwat Ratanavadee Nanagara |
2015 | ||||
| 38. | Asymptomatic cardiac involvement in Thai systemic sclerosis: Prevalence and clinical correlations withn non-cardiac manifestations (preliminary report) | Foocharoen, C. Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 | ||||
| 39. | Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma | Chingching Foocharoen Sittichai Netwijitpan Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2016 | ||||
| 40. | Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 | ||||
| 41. | Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma | Suebmee, P Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Theerakulpisut, D Nanagara, R |
2016 | ||||
| 42. | Self-assessment of skin tightness severity by scleroderma patients | Daungkum, K Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Thinkhamrop, B Nanagara, R |
2016 | ||||
| 43. | 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis | Louthrenoo, W Kasitanon, N Katchamart, W Aiewruengsurat, D Chevaisrakul, P Chiowchanwisawakit, P Dechanuwong, P Hanvivadhanakul, P Mahakkanukrauh, A Manavathongchai, S Muangchan, C Narongroeknawin, P Phumethum, V Siripaitoon, B Suesuwan, A Suwannaroj, S Uea-Areewongsa, P Ukritchon, S Asavatanabodee, P Koolvisoot, A Nanagara, R Totemchokchyakarn, K Nuntirooj, K Kitumnuaypong, T |
2017 | ||||
| 44. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13:01 allele in the Thai population | Nakkam, N. Wattanakrai, P. Jantararoungtong, T. Mahakkanukrauh, A. Tassaneeyakul, W. |
2017 | ||||
| 45. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial | Foocharoen, C. Chunlertrith, K. Mairiang, P. Mahakkanukrauh, A. Suwannaroj, S. Wantha, O. Nanagara, R. |
2017 | ||||
| 46. | Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association | , , , Katchamart, W Narongroeknawin, P Chevaisrakul, P Dechanuwong, P Mahakkanukrauh, A Kasitanon, N Pakchotanon, R Sumethkul, K Ueareewongsa, P Ukritchon, S Bhurihirun, T Duangkum, K Intapiboon, P Intongkam, S Jangsombatsiri, W Jatuworapruk, K Kositpesat, N Leungroongroj, P Lomarat, W Petcharat, C Sittivutworapant, S Suebmee, P Tantayakom, P Tipsing, W Asavatanabodee, P Chiowchanwisawakit, P Foocharoen, C Koolvisoot, A Louthrenoo, W Siripaitoon, B Totemchokchyakarn, K Kitumnuaypong, T , |
2017 | ||||
| 47. | Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. | Chingching Foocharoen Piyakarn Watcharenwong Sittichai Netwijitpan Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2017 | ||||
| 48. | Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis | Apipattarakul, R Foocharoen, C Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Limpawattana, P Nanagara, R |
2018 | ||||
| 49. | Degree of improvement after hyperbaric oxygen therapy for compromised flap and graft: A case series. | Jenwitheesuk, K. Mahakkanukrauh, A. Punjaruk, W. Jenwitheesuk, K. Surakunprapha, P. Winaikosol, K. Chowchuen, B. |
2018 | ||||
| 50. | Disease modifying anti-rheumatic drugs [dmards] used and treatment outcome of rheumatoid arthritis in rheumatology clinic, Srinagarind Hospital | Nanagara, R. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2018 | ||||
| 51. | Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry | Pongthorn Narongroeknawin Parawee Chevaisrakul Nuntana Kasitanon Tasanee Kitumnuaypong Ajanee Mahakkanukrauh Boonjing Siripaitoon Wanruchada Katchamart |
2018 | ||||
| 52. | Efficacy of Adjunctive Hyperbaric Oxygen Therapy in Osteoradionecrosis | Jenwitheesuk, K Mahakkanukrauh, A Punjaruk, W Jenwitheesuk, K Chowchuen, B Jinaporntham, S Uraiwan, K Limrattanapimpa, P |
2018 | ||||
| 53. | Poor outcome of peritoneal dialysis during scleroderma renal crisis in scleroderma patients | Siriphannon, Y. Foocharoen, C. Anutrakulchai, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2018 | ||||
| 54. | Pulmonary manifestation in systemic sclerosis in Srinagarind Hospital | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Nanagara, R. Tumsatan, P. |
2018 | ||||
| 55. | The effect of 4 milligrams intravenous zoledronic acid once yearly on bone mineral density and biochemical bone markers in systemic sclerosis patients with osteoporosis | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Pongchaiyakul, C. Nanagara, R. |
2018 | ||||
| 56. | The effects of bosentan on the survival, safety, and tolerability in pulmonary hypertension as related to diffuse cutaneous systemic sclerosis | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Kiatchoosakun, S. Wantha, O. Nanagara, R. |
2018 | ||||
| 57. | Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study | Tipparot, T Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R Pussadhamma, B Chaosuwannakit, N |
2019 | ||||
| 58. | Effect of season on clinical outcomes of Thai systemic sclerosis: analysis of the Thai national healthcare database. | Foocharoen, C Peansukwech, U Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S |
2019 | ||||
| 59. | PREVALENCE OF PERIPHERAL EOSINOPHILIA AND CLINICAL ASSOCIATIONS IN THAI SYSTEMIC SCLEROSIS PATIENTS | Chingching Foocharoen Patnarin Kongkulkiat Ajanee Mahakkanukrauh Pewpan Maleewong Intapan Wanchai Maleewong Amonrat Jumnainsong Nattiya Teawtrakul Siraphop Suwannaroj Ratanavadee Nanagara |
2019 | ||||
| 60. | TUBERCULIN SKIN TEST FOR DETECTION OF TUBERCULOSIS IN SYSTEMIC SCLEROSIS | Apichat So-Ngern Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2019 | ||||
| 61. | Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis | Rachot Wongjirattikarn Suteeraporn Chaowattanapanit Charoen Choonhakarn Apichart So-ngern Ajanee Mahakkanukrauh Chingching Foocharoen |
2020 | ||||
| 62. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis. | Krikeerati, T Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2020 | ||||
| 63. | Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study | Foocharoen, C Peansukwech, U Mahakkanukrauh, A Suwannaroj, S Pongkulkiat, P Khamphiw, P Nanagara, R |
2020 | ||||
| 64. | Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study | Burabha Pussadhamma Thapanee Tipparot Naruemol Chaosuwannakit Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2020 | ||||
| 65. | Effect of season on clinical outcomes of Thai systemic sclerosis: Analysis of the Thai national healthcare database | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2020 | ||||
| 66. | Predictors for success of hyperbaric oxygen therapy for problematic wounds | Jenwitheesuk, K. Mahakkanukrauh, A. Punjaruk, W. Jenwitheesuk, K. Winaikosol, K. Wongkonkitsin, N. Prasertcharoensuk, S. |
2020 | ||||
| 67. | Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study. | Foocharoen, C. Chunlertrith, K. Mairiang, P. Mahakkanukrauh, A. Suwannaroj, S. Wantha, O. Nanagara, R. |
2020 | ||||
| 68. | Radiation ulcer treatment with hyperbaric oxygen therapy and haemoglobin spray: Case report and literature review | Kengkart Winaikosol Pattama Punyavong Kamonwan Jenwitheesuk Palakorn Surakunprapha Ajanee Mahakkanukrauh |
2020 | ||||
| 69. | Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database | Foocharoen, C Peansukwech, U Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S |
2021 | ||||
| 70. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis | Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 | ||||
| 71. | Clinical Differences in Lupus Nephritis in Thai Patients with Systemic Lupus Erythematosus with Positive vs. Negative Anti-dsDNA Antibody | Foocharoen, C. Mahakkanukrauh, A. Nanagara, R. Suwannaroj, S. |
2021 | ||||
| 72. | Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study). | Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 | ||||
| 73. | HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients | Patompong Satapornpong Jirawat Pratoomwun Pawinee Rerknimitr Jettanong Klaewsongkram Nontaya Nakkam Thanyada Rungrotmongkol Parinya Konyoung Niwat Saksit Ajanee Mahakkanukrauh Warayuwadee Amornpinyo Usanee Khunarkornsiri Therdpong Tempark Kittipong Wantavornprasert Pimonpan Jinda Napatrupron Koomdee Thawinee Jantararoungtong Ticha Rerkpattanapipat Chuang-Wei Wang Dean Naisbitt Wichittra Tassaneeyakul Manasalak Ariyachaipanich Thapana Roonghiranwat Munir Pirmohamed Wen-Hung Chung Chonlaphat Sukasem |
2021 | ||||
| 74. | Incidence of anti-topoisomerase I antibody seroconversion and clinical association in systemic sclerosis | Srikamud, S. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 | ||||
| 75. | Incidence Rate, Causes and Predictors of Opportunistic Infection during High-Dose Steroid with and without Immunosuppressant Therapy in Thais with Systemic Lupus Erythematosus | Foocharoen, C. Mahakkanukrauh, A. Nanagara, R. Suwannaroj, S. |
2021 | ||||
| 76. | Is Adjunctive Hyperbaric Oxygen Treatment Alone or with Surgery the Proper Management for Active and Persistent Osteoradionecrosis? | Jenwitheesuk, K Mahakkanukrauh, A Punjaruk, W Vatanasapt, P Jenwitheesuk, K Surakunprapha, P Jinaporntham, S Uraiwan, K Limrattanapimpa, P |
2021 | ||||
| 77. | Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. | Satapornpong, P Pratoomwun, J Rerknimitr, P Klaewsongkram, J Nakkam, N Rungrotmongkol, T Konyoung, P Saksit, N Mahakkanukrauh, A Amornpinyo, W Khunarkornsiri, U Tempark, T Wantavornprasert, K Jinda, P Koomdee, N Jantararoungtong, T Rerkpattanapipat, T Wang, CW Naisbitt, D Tassaneeyakul, W Ariyachaipanich, M Roonghiranwat, T Pirmohamed, M Chung, WH Sukasem, C |
2021 | ||||
| 78. | Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease. | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Nanagara, R. |
2021 | ||||
| 79. | Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis | Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2021 | ||||
| 80. | Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis | Salang, L. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2021 | ||||
| 81. | Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis | Chuealee, W Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Pongchaiyakul, C Nanagara, R |
2021 | ||||
| 82. | Prevalence, Classification, and Outcomes of Pulmonary Hypertension in Thai Systemic Sclerosis | Pussadhamma, B. Tumsatan, P. Foocharoen, C. Suwannaroj, S. Nanagara, R. Mahakkanukrauh, A. |
2021 | ||||
| 83. | The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients | Yathao Paolee Chingching Foocharoen Suranut Charoensri Mayfong Mayxay Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2021 | ||||
| 84. | Development and validation of machine learning for early mortality in systemic sclerosis | Foocharoen, C Thinkhamrop, W Chaichaya, N Mahakkanukrauh, A Suwannaroj, S Thinkhamrop, B |
2022 | ||||
| 85. | Management pitfalls and prevalence of lost to follow-up due to unpredicted death in systemic sclerosis | Pongkulkiat, P. Wantha, O. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 | ||||
| 86. | Predictors for Dry Eye Diseases in Patients with Systemic Sclerosis. | Laovirojjanakul, W. Yospaiboon, Y. Anutarapongpan, O. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2022 | ||||
| 87. | Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis | Sangaroon, A Foocharoen, C Theerakulpisut, D Srichompoo, K Mahakkanukrauh, A Suwannaroj, S Seerasaporn, P Pongchaiyakul, C |
2022 | ||||
| 88. | Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis. | Thepwiwatjit, S. Charoensri, S. Sirithanaphol, W. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 | ||||
| 89. | Prevalence of moderate to severe lower urinary tract symptoms in systemic sclerosis. | Rompsaithong, U. Sirithanaphol, W. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 | ||||
| 90. | Prevalence of peripheral eosinophilia and clinical associations in systemic sclerosis patients. | Foocharoen, C. Mahakkanukrauh, A. Maleewong, W. Jumnainsong, A. Teawtrakul, N. Suwannaroj, S. Nanagara, R. |
2022 | ||||
| 91. | Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis. | Pongkulkiat, P. Thinkhamrop, B. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 | ||||
| 92. | Skin thickness affects the result of tuberculin skin test in systemic sclerosis. | So-ngern, A. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2022 | ||||
| 93. | Attitudes and factors affecting decision-making regarding COVID-19 vaccination among autoimmune rheumatic disease patients. | Wantha, O. Mahakkanukrauh, A. Tuydaung, K. Donsrichan, W. Yingyaun, K. Kaewmeun, S. Suwannaroj, S. Foocharoen, C. |
2023 | ||||
| 94. | Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients. | Foocharoen, C. Kingkaew, P. Teerawattananon, Y. Mahakkanukrauh, A. Suwannaroj, S. Manasirisuk, W. Chaiyarit, J. Sangchan, A. |
2023 | ||||
| 95. | Effects of Low-dose Aspirin on Serum Uric Acid among Asymptomatic Hyperuricemia Patients with Cardiovascular Risk Factors | Silisay, V. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Nanagara, R. |
2023 | ||||
| 96. | Fingerprint comparison between before disease onset and after systemic sclerosis diagnosis: a monocentric cross-sectional study | Sriwong, WT Srisangwarn, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 | ||||
| 97. | Incidence and Prevalence of Septic Arthritis in Thailand: A Database from the Ministry of Public Health | Foocharoen, T Onchan, T Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 | ||||
| 98. | Incidence and prevalence of systemic sclerosis in Thailand in year 2017-2020: a database from the Ministry of Public Health. | Foocharoen, C Ngamjarus, C Pattanittum, P Suwannaroj, S Pongkulkiat, P Onchan, T Wattanasukchai, L Chaiyarit, J Mahakkanukrauh, A |
2023 | ||||
| 99. | Incidence and prevalence of systemic sclerosis in Thailand in year 2017–2020: a database from the Ministry of Public Health | Foocharoen, C. Ngamjarus, C. Pattanittum, P. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Wattanasukchai, L. Chaiyarit, J. Mahakkanukrauh, A. |
2023 | ||||
| 100. | Management review of scleroderma renal crisis: An update with practical pointers. | Foocharoen, C. Tonsawan, P. Pongkulkiat, P. Anutrakulchai, S. Mahakkanukrauh, A. Suwannaroj, S. |
2023 | ||||
| 101. | Prevalence of erectile dysfunction in Thai scleroderma patients and associated factors | Sirithanaphol, W Mahakkanukrauh, A Nanagara, R Foocharoen, C |
2023 | ||||
| 102. | Prevalence of low trabecular bone score and its association with disease severity and activity in patients with axial spondyloarthritis | Saisirivechakun, P Mahakkanukrauh, A Pongchaiyakul, C Boonya-Ussadorn, T Narongroeknawin, P Pakchotanon, R Assavatanabodee, P Chaiamnuay, S |
2023 | ||||
| 103. | Safety and effectiveness of intravenous CT-P13 in inflammatory arthritis: post-marketing surveillance study in Thailand | Mahakkanukrauh, A Chaiamnuay, S Koolvisoot, A Kitamnuayphong, T Manavathongchai, S Osiri, M Louthrenoo, W Uea-Areewongsa, P Ahn, K Jung, N Kim, M Lee, S Kim, H Kim, S |
2023 | ||||
| 104. | Sleep quality and clinical association with sleep disturbance in systemic sclerosis. | Wongthawa, N. So-gnern, A. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2023 | ||||
| 105. | Treatment Outcome of Ankylosing Spondylitis in Srinagarind Hospital | Uthaiphan, S. Foocharoen, C. Suwannaroj, S. Pongkulkiat, P. Mahakkanukrauh, A. |
2023 | ||||
| 106. | Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study. | Werakiat, J. Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2024 | ||||
| 107. | Incidence and prevalence of idiopathic inflammatory myopathies in Thailand from the Ministry of Public Health data analysis | Onchan, T Foocharoen, C Pongkulkiat, P Suwannaroj, S Mahakkanukrauh, A |
2024 | ||||
| 108. | Incidence of Systemic Vasculitis and Clinical Outcomes in Systemic Sclerosis: 2-Years Follow-Up of Asymptomatic Positive for Anti-Neutrophilic Cytoplasmic Antibody | Suwannamajo, R Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2024 | ||||
| 109. | Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients. | Mulalin, K. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Kasa, S. Foocharoen, C. |
2024 | ||||
| 110. | Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up | Mahakkanukrauh, A Foocharoen, C Chaosuwannakit, N Suwannaroj, S Pongkulkiat, P Onchan, T Pussadhamma, B |
2024 | ||||
| 111. | Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study | Rattanakaemakorn, P Chevaisrakul, P Wongpraparut, C Chiowchanwisawakit, P Tovanabutra, N Tantiwong, P Amornpinyo, W Chakkavittumrong, P Hanvivadhanakul, P Chaiamnuay, S Laodheerasiri, S Pattamadilok, B Choonhakarn, C Mahakkanukrauh, A Aiewruengsurat, D Sangmala, S Pretikul, N Sumethkul, K Satpanich, P Boonsiri, M Sangob, N Asawanonda, P , |
2024 | ||||
| 112. | The incidence and prevalence of ankylosing spondylitis in Thailand using ministry of public health database | Mahakkanukrauh, A Suwannaroj, S Pongkulkiat, P Onchan, T Foocharoen, C |
2024 | ||||
| 113. | Botulinum toxin injection versus steroid injection in tennis elbow: a systematic review and meta-analysis | Tummai, S. Ngamjarus, C. Mahakkanukrauh, A. Sawanyawisuth, K. Phadungwong, P. Srichaphan, T. |
2025 | ||||
| 114. | Case Report: Chalk-Like Synovial Fluid and Calcified Synovium in Systemic Sclerosis Overlapping With Rheumatoid Arthritis Stabilized by Rituximab | Khounthep, A Thummaroj, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2025 | ||||
| 115. | Clinical outcomes and associated factors with mortality in systemic sclerosis patients with sarcopenia. | Hongkanjanapong, S. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 | ||||
| 116. | Correlation Between the Peak of Skin Thickness Progression Rate and Onset of Cardiopulmonary Involvement in Thai Systemic Sclerosis Patients | Rujirawinitchai, P. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. |
2025 | ||||
| 117. | Effects of a Self-Management Telehealth Program on Improving Strength and Hand Function in Systemic Sclerosis Patients: A Randomized Controlled Trial | Wantha, O. Mahakkanukrauh, A. Suwannaroj, S. Tuydaung, K. Methakanjanasak, N. Srichomphu, K. Kraipoj, J. Foocharoen, C. |
2025 | ||||
| 118. | Efficacy and safety of 2% isosorbide cream in systemic sclerosis patients with digital ulcers and Raynaud's phenomenon | Namvijit, S Foocharoen, C Suwannaroj, S Pongkulkait, P Onchan, T Mahakkanukrauh, A |
2025 | ||||
| 119. | Efficacy of Cannabis Oil in Improving Subjective Sleep Quality in Systemic Sclerosis: A Prospective Placebo-Controlled Study | So-ngern, A. Sripanichkulchai, B. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Kanokmedhakul, S. Foocharoen, C. |
2025 | ||||
| 120. | Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis. | Mahakkanukrauh, A. Ngamjarus, C. Pattanittum, P. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 | ||||
| 121. | Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions. | Srisuriyachanchai, W. Foocharoen, C. Mahakkanukrauh, A. Cox, A.R. Jarernsiripornkul, N. |
2025 | ||||
| 122. | Incidence and prevalence of rheumatoid arthritis in Thailand based on National administrative health data and a comprehensive literature review | Senaveenin, N Mahakkanukrauh, A Foocharoen, C Suwannaroj, S Onchan, T Pongkulkiat, P |
2025 | ||||
| 123. | Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset | Chaovanitkul, C. Onchan, T. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 | ||||
| 124. | Unraveling the relationship between disordered sleep and systemic sclerosis outcomes | So-Gnern, A. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 | ||||
| 125. | Validation and cross-cultural adaptation of the Thai version of the Systemic Sclerosis Health Assessment Questionnaire. | Ruangnopparut, R. Osiri, M. Suwannaroj, S. Mahakkanukrauh, A. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 | Count | 105 | 83 | 57 | 3 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Quinolones and Salmonella septic arthritis | Mootsikapun, P. Suwannaroj, S. Mahakkanukrauh, A. Nanagara, R. |
2002 |
Journal of the Medical Association of Thailand 9 (85), pp. 984-989 |
||||||||
| 2. | Exertional rhabdomyolysis following excessive exercise of university freshman cheer-training | Mahakkanukrauh, A. Sangchan, A. Mootsikapun, P. |
2003 |
Journal of the Medical Association of Thailand 8 (86), pp. 789-792 |
||||||||
| 3. | Tuberculous pyomyositis | Mootsikapun, P. Suwannaroj, S. Mahakkanukrauh, A. Nanagara, R. |
2003 |
Journal of the Medical Association of Thailand 5 (86), pp. 477-481 |
||||||||
| 4. | Outward migration of Gnathostoma spinigerum in interferon alpha treated hepatitis C patient | Sangchan, A. Sawanyawisuth, K. Intapan, P.M.A. Mahakkanukrauh, A. |
2006 |
Parasitology International 1 (55), pp. 31-32 |
||||||||
| 5. | Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): A study at srinagarind hospital | Foocharoen, C. Nanagara, R. Salang, L. Suwannaroj, S. Mahakkanukrauh, A. |
2009 |
Journal of the Medical Association of Thailand 2 (92), pp. 167-174 |
||||||||
| 6. | Clinical features of tuberculous septic arthritis in Khon Kaen, Thailand: A 10-year retrospective study | Foocharoen, C. Nanagara, R. Suwannaroj, S. Mahakkanukrauh, A. |
2010 |
Southeast Asian Journal of Tropical Medicine and Public Health 6 (41), pp. 1438-1446 |
||||||||
| 7. | Clinical features and disease outcomes of undifferentiated arthritis in Thailand | Foocharoen, C. Nanagara, R. Suwannaroj, S. Mahakkanukrauh, A. |
2011 |
International Journal of Rheumatic Diseases 3 (14), pp. e14-e21 |
||||||||
| 8. | Erratum: Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients (Clin Rheumatol (2011) 30 (1263) DOI 10.1007/s10067-011-1744-z) | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2011 |
Clinical Rheumatology 9 (30), pp. 1263 |
||||||||
| 9. | Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand | Foocharoen, C. Nanagara, R. Kiatchoosakun, S. Suwannaroj, S. Mahakkanukrauh, A. |
2011 |
International Journal of Rheumatic Diseases 3 (14), pp. 282-289 |
||||||||
| 10. | Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2011 |
Clinical Rheumatology 9 (30), pp. 1235-1240 |
||||||||
| 11. | Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment | Foocharoen, C. Nanagara, R. Suwannaroj, S. Mahakkanukrauh, A. |
2011 |
International Journal of Rheumatic Diseases 4 (14), pp. 353-360 |
||||||||
| 12. | Synovial fluid adenosine deaminase activity to diagnose tuberculous septic arthritis | Foocharoen, C. Mahakkanukrauh, A. Paupairoj, A. Teerajetgul, Y. Nanagara, R. |
2011 |
Southeast Asian Journal of Tropical Medicine and Public Health 2 (42), pp. 331-337 |
||||||||
| 13. | Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia | Wanitpongpun, C. Teawtrakul, N. Mahakkanukrauh, A. Siritunyaporn, S. Sirijerachai, C. Chansung, G. |
2012 |
Clinical and Experimental Rheumatology 6 (30), pp. 825-829 |
||||||||
| 14. | Incidence rate and causes of infection in Thai systemic sclerosis patients | Foocharoen, C. Siriphannon, Y. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2012 |
International Journal of Rheumatic Diseases 3 (15), pp. 277-283 |
||||||||
| 15. | Pattern of skin thickness progression and clinical correlation in thai scleroderma patients | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2012 |
International Journal of Rheumatic Diseases 5 (15), pp. e90-e95 |
||||||||
| 16. | Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients | Kunyakham, W. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2012 |
Asian Pacific Journal of Allergy and Immunology 2 (30), pp. 152-157 |
||||||||
| 17. | Admission rate and characteristics of hospitalized systemic connective tissue disorders: Analysis from a nationwide Thailand healthcare database | Foocharoen, C. Thavornpitak, Y. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2013 |
International Journal of Rheumatic Diseases 1 (16), pp. 41-46 |
||||||||
| 18. | Features and outcomes of hospitalized Thai patients with pyogenic arthritis: Analysis from the nationwide hospital database | Mahakkanukrauh, A. Thavornpitak, Y. Foocharoen, C. Suwannaroj, S. Nanagara, R. |
2013 |
International Journal of Rheumatic Diseases 4 (16), pp. 387-391 |
||||||||
| 19. | Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis | Netwijitpan, S. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2013 |
Clinical Rheumatology 3 (32), pp. 361-367 |
||||||||
| 20. | Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2013 |
Asian Pacific Journal of Allergy and Immunology 4 (31), pp. 314-319 |
||||||||
| 21. | Clinical characteristics and mortality in systemic sclerosis: A comparison between early- and late-referred diseases | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2014 |
Journal of the Medical Association of Thailand 1 (97), pp. 28-35 |
||||||||
| 22. | Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: Is annual echocardiographic screening necessary? | Foocharoen, C. Mahakkanukrauh, A. Pussadhamma, B. Netwijitpan, S. Suwannaroj, S. Nanagara, R. |
2014 |
Journal of Clinical Rheumatology 5 (20), pp. 268-274 |
||||||||
| 23. | Prevalence and causes of loss to follow-up among patients with systemic sclerosis | Foocharoen, C. Yenrom, P. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2014 |
Journal of Clinical Rheumatology 8 (20), pp. 456 |
||||||||
| 24. | Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Nanagara, R. |
2015 |
Archives of Medical Science 6 (11), pp. 1255-1260 |
||||||||
| 25. | Inter-and intra-observer reliability of modified rodnan skin score assessment in Thai systemic sclerosis patients: A validation for multicenter scleroderma cohort study | Foocharoen, C. Thinkhamrop, B. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Towiwat, P. Nanagara, R. |
2015 |
Journal of the Medical Association of Thailand 11 (98), pp. 1082-1088 |
||||||||
| 26. | Asymptomatic cardiac involvement in Thai systemic sclerosis: Prevalence and clinical correlations withn non-cardiac manifestations (preliminary report) | Foocharoen, C. Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 |
Rheumatology (United Kingdom) 9 (54), pp. 1616-1621 |
||||||||
| 27. | Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 |
International Journal of Rheumatic Diseases 9 (19), pp. 913-923 |
||||||||
| 28. | Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 |
International Journal of Rheumatic Diseases 3 (19), pp. 312-320 |
||||||||
| 29. | Self-assessment of skin tightness severity by scleroderma patients | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2016 |
International Journal of Rheumatic Diseases 10 (19), pp. 989-995 |
||||||||
| 30. | 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis | Hanvivadhanakul, P. Mahakkanukrauh, A. Suwannaroj, S. Koolvisoot, A. Nanagara, R. Nuntirooj, K. |
2017 |
International Journal of Rheumatic Diseases 9 (20), pp. 1166-1184 |
||||||||
| 31. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B ∗ 13:01 allele in the Thai population | Nakkam, N. Wattanakrai, P. Jantararoungtong, T. Mahakkanukrauh, A. Tassaneeyakul, W. |
2017 |
Pharmacogenetics and Genomics 12 (27), pp. 429-437 |
||||||||
| 32. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: Randomized placebo-controlled trial | Foocharoen, C. Chunlertrith, K. Mairiang, P. Mahakkanukrauh, A. Suwannaroj, S. Wantha, O. Nanagara, R. |
2017 |
Rheumatology (United Kingdom) 2 (56), pp. 214-222 |
||||||||
| 33. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial | Foocharoen, C. Chunlertrith, K. Mairiang, P. Mahakkanukrauh, A. Suwannaroj, S. Wantha, O. Nanagara, R. |
2017 |
Rheumatology (Oxford, England) 2 (56), pp. 214-222 |
||||||||
| 34. | Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association | Mahakkanukrauh, A. Foocharoen, C. Koolvisoot, A. |
2017 |
International Journal of Rheumatic Diseases 9 (20), pp. 1142-1165 |
||||||||
| 35. | Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2017 |
International Journal of Rheumatic Diseases 10 (20), pp. 1572-1581 |
||||||||
| 36. | Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis | Foocharoen, C. Netwijitpan, S. Mahakkanukrauh, A. Suwannaroj, S. Limpawattana, P. Nanagara, R. |
2018 |
Clinical and Experimental Rheumatology (36), pp. S76-S81 |
||||||||
| 37. | Degree of improvement after hyperbaric oxygen therapy for compromised flap and graft: A case series. | Jenwitheesuk, K. Mahakkanukrauh, A. Punjaruk, W. Jenwitheesuk, K. Surakunprapha, P. Winaikosol, K. Chowchuen, B. |
2018 |
Biomedical Research (India) 16 (29), pp. 3177-3180 |
||||||||
| 38. | Disease modifying anti-rheumatic drugs [dmards] used and treatment outcome of rheumatoid arthritis in rheumatology clinic, Srinagarind Hospital | Nanagara, R. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S31-S39 |
||||||||
| 39. | Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry | Mahakkanukrauh, A. | 2018 |
International Journal of Rheumatic Diseases 1 (21), pp. 170-178 |
||||||||
| 40. | Efficacy of Adjunctive Hyperbaric Oxygen Therapy in Osteoradionecrosis | Jenwitheesuk, K. Mahakkanukrauh, A. Punjaruk, W. Jenwitheesuk, K. Chowchuen, B. Jinaporntham, |
2018 |
BioResearch Open Access 1 (7), pp. 145-149 |
||||||||
| 41. | Poor outcome of peritoneal dialysis during scleroderma renal crisis in scleroderma patients | Siriphannon, Y. Foocharoen, C. Anutrakulchai, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S235-S243 |
||||||||
| 42. | Pulmonary manifestation in systemic sclerosis in Srinagarind Hospital | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Nanagara, R. Tumsatan, P. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S213-S219 |
||||||||
| 43. | The effect of 4 milligrams intravenous zoledronic acid once yearly on bone mineral density and biochemical bone markers in systemic sclerosis patients with osteoporosis | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Pongchaiyakul, C. Nanagara, R. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S125-S130 |
||||||||
| 44. | The effects of bosentan on the survival, safety, and tolerability in pulmonary hypertension as related to diffuse cutaneous systemic sclerosis | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Kiatchoosakun, S. Wantha, O. Nanagara, R. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S51-S55 |
||||||||
| 45. | Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Pussadhamma, B. Chaosuwannakit, N. |
2019 |
International Journal of Rheumatic Diseases 12 (22), pp. 2125-2133 |
||||||||
| 46. | Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis | Chaowattanapanit, S. Choonhakarn, C. So-Ngern, A. Mahakkanukrauh, A. Foocharoen, C. |
2020 |
Case Reports in Dermatology 1 (12), pp. 57-63 |
||||||||
| 47. | Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2020 |
International Journal of Rheumatic Diseases 7 (23), pp. 945-957 |
||||||||
| 48. | Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study | Pussadhamma, B. Tipparot, T. Chaosuwannakit, N. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2020 |
International Journal of Rheumatology (2020), pp. |
||||||||
| 49. | Effect of season on clinical outcomes of Thai systemic sclerosis: Analysis of the Thai national healthcare database | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2020 |
Modern Rheumatology 6 (30), pp. 1025-1032 |
||||||||
| 50. | Predictors for success of hyperbaric oxygen therapy for problematic wounds | Jenwitheesuk, K. Mahakkanukrauh, A. Punjaruk, W. Jenwitheesuk, K. Winaikosol, K. Wongkonkitsin, N. Prasertcharoensuk, S. |
2020 |
Wound Medicine (30), pp. |
||||||||
| 51. | Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study | Foocharoen, C. Chunlertrith, K. Mairiang, P. Mahakkanukrauh, A. Suwannaroj, S. Wantha, O. Nanagara, R. |
2020 |
Scientific Reports 1 (10), pp. |
||||||||
| 52. | Radiation ulcer treatment with hyperbaric oxygen therapy and haemoglobin spray: Case report and literature review | Winaikosol, K. Jenwitheesuk, K. Surakunprapha, P. Mahakkanukrauh, A. |
2020 |
Journal of Wound Care 8 (29), pp. 452-456 |
||||||||
| 53. | Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 54. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis | Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 |
Modern Rheumatology 3 (31), pp. 649-656 |
||||||||
| 55. | Clinical Differences in Lupus Nephritis in Thai Patients with Systemic Lupus Erythematosus with Positive vs. Negative Anti-dsDNA Antibody | Foocharoen, C. Mahakkanukrauh, A. Nanagara, R. Suwannaroj, S. |
2021 |
Journal of the Medical Association of Thailand (104), pp. S43-S49 |
||||||||
| 56. | Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study) | Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 |
American Journal of the Medical Sciences 6 (362), pp. 576-583 |
||||||||
| 57. | HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients | Nakkam, N. Mahakkanukrauh, A. Jantararoungtong, T. Tassaneeyakul, W. |
2021 |
Frontiers in Immunology (12), pp. |
||||||||
| 58. | Incidence of anti-topoisomerase I antibody seroconversion and clinical association in systemic sclerosis | Srikamud, S. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2021 |
Asia-Pacific Journal of Science and Technology 2 (26), pp. |
||||||||
| 59. | Incidence Rate, Causes and Predictors of Opportunistic Infection during High-Dose Steroid with and without Immunosuppressant Therapy in Thais with Systemic Lupus Erythematosus | Foocharoen, C. Mahakkanukrauh, A. Nanagara, R. Suwannaroj, S. |
2021 |
Journal of the Medical Association of Thailand (104), pp. S50-S55 |
||||||||
| 60. | Is adjunctive hyperbaric oxygen treatment alone or with surgery the proper management for active and persistent osteoradionecrosis? | Jenwitheesuk, K. Mahakkanukrauh, A. Punjaruk, W. Vatanasapt, P. Jenwitheesuk, K. Surakunprapha, P. Jinaporntham, S. |
2021 |
Advances in Skin and Wound Care 2 (34), pp. |
||||||||
| 61. | Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease | Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Nanagara, R. |
2021 |
Clinical Rheumatology 1 (40), pp. 205-211 |
||||||||
| 62. | Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis | Salang, L. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2021 |
Clinical Rheumatology 6 (40), pp. 2267-2275 |
||||||||
| 63. | Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis | Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Pongchaiyakul, C. Nanagara, R. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 64. | Prevalence, Classification, and Outcomes of Pulmonary Hypertension in Thai Systemic Sclerosis | Pussadhamma, B. Tumsatan, P. Foocharoen, C. Suwannaroj, S. Nanagara, R. Mahakkanukrauh, A. |
2021 |
Journal of the Medical Association of Thailand (104), pp. S88-S96 |
||||||||
| 65. | The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients | Foocharoen, C. Charoensri, S. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 66. | Development and validation of machine learning for early mortality in systemic sclerosis | Foocharoen, C. Thinkhamrop, W. Chaichaya, N. Mahakkanukrauh, A. Suwannaroj, S. Thinkhamrop, B. |
2022 |
Scientific Reports 1 (12), pp. |
||||||||
| 67. | Management pitfalls and prevalence of lost to follow-up due to unpredicted death in systemic sclerosis | Pongkulkiat, P. Wantha, O. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 |
Asia-Pacific Journal of Science and Technology 5 (27), pp. |
||||||||
| 68. | Predictors for Dry Eye Diseases in Patients with Systemic Sclerosis | Laovirojjanakul, W. Yospaiboon, Y. Anutarapongpan, O. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2022 |
Clinical Ophthalmology (16), pp. 3447-3455 |
||||||||
| 69. | Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis | Sangaroon, A. Foocharoen, C. Theerakulpisut, D. Srichompoo, K. Mahakkanukrauh, A. Suwannaroj, S. Seerasaporn, P. Pongchaiyakul, C. |
2022 |
Scientific Reports 1 (12), pp. |
||||||||
| 70. | Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis | Thepwiwatjit, S. Charoensri, S. Sirithanaphol, W. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 |
Journal of Scleroderma and Related Disorders (), pp. |
||||||||
| 71. | Prevalence of moderate to severe lower urinary tract symptoms in systemic sclerosis | Rompsaithong, U. Sirithanaphol, W. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 |
Rheumatology (Oxford, England) 10 (61), pp. 4016-4023 |
||||||||
| 72. | Prevalence of peripheral eosinophilia and clinical associations in systemic sclerosis patients | Foocharoen, C. Mahakkanukrauh, A. Maleewong, W. Jumnainsong, A. Teawtrakul, N. Suwannaroj, S. Nanagara, R. |
2022 |
American Journal of the Medical Sciences 6 (363), pp. 519-525 |
||||||||
| 73. | Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis | Pongkulkiat, P. Thinkhamrop, B. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2022 |
BMC Rheumatology 1 (6), pp. |
||||||||
| 74. | Skin thickness affects the result of tuberculin skin test in systemic sclerosis | So-ngern, A. Mahakkanukrauh, A. Suwannaroj, S. Nanagara, R. Foocharoen, C. |
2022 |
BMC Rheumatology 1 (6), pp. |
||||||||
| 75. | Attitudes and factors affecting decision-making regarding COVID-19 vaccination among autoimmune rheumatic disease patients | Wantha, O. Mahakkanukrauh, A. Tuydaung, K. Donsrichan, W. Yingyaun, K. Kaewmeun, S. Suwannaroj, S. Foocharoen, C. |
2023 |
International Journal of Rheumatic Diseases 4 (26), pp. 751-758 |
||||||||
| 76. | Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients | Foocharoen, C. Kingkaew, P. Teerawattananon, Y. Mahakkanukrauh, A. Suwannaroj, S. Manasirisuk, W. Chaiyarit, J. Sangchan, A. |
2023 |
International Journal of Rheumatic Diseases 10 (26), pp. 2037-2046 |
||||||||
| 77. | Effects of Low-dose Aspirin on Serum Uric Acid among Asymptomatic Hyperuricemia Patients with Cardiovascular Risk Factors | Silisay, V. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Netwijitpan, S. Nanagara, R. |
2023 |
Journal of the Medical Association of Thailand 4 (104), pp. S82-S88 |
||||||||
| 78. | Fingerprint comparison between before disease onset and after systemic sclerosis diagnosis: a monocentric cross-sectional study | Sriwong, W.T. Srisangwarn, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2023 |
Clinical Rheumatology 1 (42), pp. 117-124 |
||||||||
| 79. | Incidence and Prevalence of Septic Arthritis in Thailand: A Database from the Ministry of Public Health | Foocharoen, T. Onchan, T. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2023 |
Open Access Rheumatology: Research and Reviews (15), pp. 213-222 |
||||||||
| 80. | Incidence and prevalence of systemic sclerosis in Thailand in year 2017–2020: a database from the Ministry of Public Health | Foocharoen, C. Ngamjarus, C. Pattanittum, P. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Wattanasukchai, L. Chaiyarit, J. Mahakkanukrauh, A. |
2023 |
Clinical Rheumatology 7 (42), pp. 1767-1774 |
||||||||
| 81. | Management review of scleroderma renal crisis: An update with practical pointers | Foocharoen, C. Tonsawan, P. Pongkulkiat, P. Anutrakulchai, S. Mahakkanukrauh, A. Suwannaroj, S. |
2023 |
Modern rheumatology 1 (33), pp. 12-20 |
||||||||
| 82. | Prevalence of erectile dysfunction in Thai scleroderma patients and associated factors | Sirithanaphol, W. Mahakkanukrauh, A. Nanagara, R. Foocharoen, C. |
2023 |
PLoS ONE 1 January (18), pp. |
||||||||
| 83. | Prevalence of low trabecular bone score and its association with disease severity and activity in patients with axial spondyloarthritis | Saisirivechakun, P. Mahakkanukrauh, A. Pongchaiyakul, C. Boonya-ussadorn, T. Narongroeknawin, P. Pakchotanon, R. Assavatanabodee, P. Chaiamnuay, S. |
2023 |
Scientific Reports 1 (13), pp. |
||||||||
| 84. | Safety and effectiveness of intravenous CT-P13 in inflammatory arthritis: post-marketing surveillance study in Thailand | Mahakkanukrauh, A. Chaiamnuay, S. Koolvisoot, A. Kitamnuayphong, T. Manavathongchai, S. Osiri, M. Louthrenoo, W. Uea-Areewongsa, P. Ahn, K. Jung, N. Kim, M. Lee, S. Kim, H. Kim, S. |
2023 |
Immunotherapy 14 (15), pp. 1143-1155 |
||||||||
| 85. | Sleep quality and clinical association with sleep disturbance in systemic sclerosis | Wongthawa, N. So-gnern, A. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2023 |
BMC Rheumatology 1 (7), pp. |
||||||||
| 86. | Treatment Outcome of Ankylosing Spondylitis in Srinagarind Hospital | Uthaiphan, S. Foocharoen, C. Suwannaroj, S. Pongkulkiat, P. Mahakkanukrauh, A. |
2023 |
Journal of the Medical Association of Thailand 4 (104), pp. S89-S93 |
||||||||
| 87. | Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study | Werakiat, J. Pussadhamma, B. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2024 |
Rheumatology and Immunology Research 2 (5), pp. 107-116 |
||||||||
| 88. | Incidence and prevalence of idiopathic inflammatory myopathies in Thailand from the Ministry of Public Health data analysis | Onchan, T. Foocharoen, C. Pongkulkiat, P. Suwannaroj, S. Mahakkanukrauh, A. |
2024 |
Scientific Reports 1 (14), pp. |
||||||||
| 89. | Incidence of Systemic Vasculitis and Clinical Outcomes in Systemic Sclerosis: 2-Years Follow-Up of Asymptomatic Positive for Anti-Neutrophilic Cytoplasmic Antibody | Suwannamajo, R. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2024 |
Clinical, Cosmetic and Investigational Dermatology (17), pp. 301-309 |
||||||||
| 90. | Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients | Mulalin, K. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Kasa, S. Foocharoen, C. |
2024 |
Scientific Reports 1 (14), pp. |
||||||||
| 91. | Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up | Mahakkanukrauh, A. Foocharoen, C. Chaosuwannakit, N. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Pussadhamma, B. |
2024 |
Rheumatology and Immunology Research 2 (5), pp. 117-125 |
||||||||
| 92. | Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study | Rattanakaemakorn, P. Chevaisrakul, P. Wongpraparut, C. Chiowchanwisawakit, P. Tovanabutra, N. Tantiwong, P. Amornpinyo, W. Chakkavittumrong, P. Hanvivadhanakul, P. Chaiamnuay, S. Laodheerasiri, S. Pattamadilok, B. Choonhakarn, C. Mahakkanukrauh, A. Aiewruengsurat, D. Sangmala, S. Pretikul, N. Sumethkul, K. Satpanich, P. Boonsiri, M. |
2024 |
Dermatology and Therapy 12 (14), pp. 3229-3241 |
||||||||
| 93. | The incidence and prevalence of ankylosing spondylitis in Thailand using ministry of public health database | Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2024 |
Scientific Reports 1 (14), pp. |
||||||||
| 94. | Botulinum toxin injection versus steroid injection in tennis elbow: a systematic review and meta-analysis | Tummai, S. Ngamjarus, C. Mahakkanukrauh, A. Sawanyawisuth, K. Phadungwong, P. Srichaphan, T. |
2025 |
Gazzetta Medica Italiana Archivio Per Le Scienze Mediche 3 (184), pp. 236-242 |
||||||||
| 95. | Case Report: Chalk-Like Synovial Fluid and Calcified Synovium in Systemic Sclerosis Overlapping With Rheumatoid Arthritis Stabilized by Rituximab | Khounthep, A. Thummaroj, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 |
International Journal of Rheumatic Diseases 7 (28), pp. |
||||||||
| 96. | Clinical outcomes and associated factors with mortality in systemic sclerosis patients with sarcopenia | Hongkanjanapong, S. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 |
American Journal of the Medical Sciences 1 (369), pp. 35-43 |
||||||||
| 97. | Correlation Between the Peak of Skin Thickness Progression Rate and Onset of Cardiopulmonary Involvement in Thai Systemic Sclerosis Patients | Rujirawinitchai, P. Foocharoen, C. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. |
2025 |
Journal of Clinical Medicine 7 (14), pp. |
||||||||
| 98. | Effects of a Self-Management Telehealth Program on Improving Strength and Hand Function in Systemic Sclerosis Patients: A Randomized Controlled Trial | Wantha, O. Mahakkanukrauh, A. Suwannaroj, S. Tuydaung, K. Methakanjanasak, N. Srichomphu, K. Kraipoj, J. Foocharoen, C. |
2025 |
Life 7 (15), pp. |
||||||||
| 99. | Efficacy and safety of 2% isosorbide cream in systemic sclerosis patients with digital ulcers and Raynaud's phenomenon | Namvijit, S. Foocharoen, C. Suwannaroj, S. Pongkulkait, P. Onchan, T. Mahakkanukrauh, A. |
2025 |
Rheumatology and Immunology Research 1 (6), pp. 52-58 |
||||||||
| 100. | Efficacy of Cannabis Oil in Improving Subjective Sleep Quality in Systemic Sclerosis: A Prospective Placebo-Controlled Study | So-ngern, A. Sripanichkulchai, B. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Kanokmedhakul, S. Foocharoen, C. |
2025 |
Life 5 (15), pp. |
||||||||
| 101. | Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis | Mahakkanukrauh, A. Ngamjarus, C. Pattanittum, P. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 |
Annals of Medicine 1 (57), pp. |
||||||||
| 102. | Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions | Srisuriyachanchai, W. Foocharoen, C. Mahakkanukrauh, A. Cox, A.R. Jarernsiripornkul, N. |
2025 |
International Journal of Clinical Pharmacy 3 (47), pp. 726-736 |
||||||||
| 103. | Incidence and prevalence of rheumatoid arthritis in Thailand based on National administrative health data and a comprehensive literature review | Senaveenin, N. Mahakkanukrauh, A. Foocharoen, C. Suwannaroj, S. Onchan, T. Pongkulkiat, P. |
2025 |
Scientific Reports 1 (15), pp. |
||||||||
| 104. | Redefining Systemic Sclerosis Classification: Anti-Topoisomerase Antibody as a Superior Predictor of Interstitial Lung Disease and Skin Progression Compared to Limited Cutaneous Systemic Sclerosis Subset | Chaovanitkul, C. Onchan, T. Pongkulkiat, P. Mahakkanukrauh, A. Suwannaroj, S. Foocharoen, C. |
2025 |
Life 7 (15), pp. |
||||||||
| 105. | Unraveling the relationship between disordered sleep and systemic sclerosis outcomes | So-Gnern, A. Mahakkanukrauh, A. Suwannaroj, S. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 |
Current Opinion in Rheumatology (), pp. |
||||||||
| 106. | Validation and cross-cultural adaptation of the Thai version of the Systemic Sclerosis Health Assessment Questionnaire | Ruangnopparut, R. Osiri, M. Suwannaroj, S. Mahakkanukrauh, A. Pongkulkiat, P. Onchan, T. Foocharoen, C. |
2025 |
Clinical Rheumatology 8 (44), pp. 3235-3243 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Quinolones and Salmonella septic arthritis. | Mootsikapun, P Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2002 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 9 (85), pp. 984-9 |
|
| 2. | Exertional rhabdomyolysis following excessive exercise of university freshman cheer-training. | Mahakkanukrauh, A Sangchan, A Mootsikapun, P |
2003 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 8 (86), pp. 789-92 |
|
| 3. | Tuberculous pyomyositis. | Mootsikapun, P Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2003 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 5 (86), pp. 477-81 |
|
| 4. | Outward migration of Gnathostoma spinigerum in interferon alpha treated hepatitis C patient. | Sangchan, A Sawanyawisuth, K Intapan, PM Mahakkanukrauh, A |
2006 |
Parasitology international 1 (55), pp. 31-2 |
|
| 5. | Pregnancy and disease outcome in patients with systemic lupus erythematosus (SLE): a study at Srinagarind Hospital. | Foocharoen, C Nanagara, R Salang, L Suwannaroj, S Mahakkanukrauh, A |
2009 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2 (92), pp. 167-74 |
|
| 6. | Clinical features of tuberculous septic arthritis in Khon Kaen, Thailand: a 10-year retrospective study. | Foocharoen, C Nanagara, R Foocharoen, T Mootsikapun, P Suwannaroj, S Mahakkanukrauh, A |
2010 |
The Southeast Asian journal of tropical medicine and public health 6 (41), pp. 1438-46 |
|
| 7. | Clinical features and disease outcomes of undifferentiated arthritis in Thailand. | Foocharoen, C Nanagara, R Suwannaroj, S Mahakkanukrauh, A |
2011 |
International journal of rheumatic diseases 3 (14), pp. e14-21 |
|
| 8. | Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients. | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2011 |
Clinical rheumatology 9 (30), pp. 1235-40 |
|
| 9. | Synovial fluid adenosine deaminase activity to diagnose tuberculous septic arthritis. | Foocharoen, C Sarntipipattana, C Foocharoen, T Mahakkanukrauh, A Paupairoj, A Teerajetgul, Y Nanagara, R |
2011 |
The Southeast Asian journal of tropical medicine and public health 2 (42), pp. 331-7 |
|
| 10. | Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment. | Foocharoen, C Nanagara, R Suwannaroj, S Mahakkanukrauh, A |
2011 |
International journal of rheumatic diseases 4 (14), pp. 353-60 |
|
| 11. | Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand. | Foocharoen, C Nanagara, R Kiatchoosakun, S Suwannaroj, S Mahakkanukrauh, A |
2011 |
International journal of rheumatic diseases 3 (14), pp. 282-9 |
|
| 12. | Incidence rate and causes of infection in Thai systemic sclerosis patients. | Foocharoen, C Siriphannon, Y Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 |
International journal of rheumatic diseases 3 (15), pp. 277-83 |
|
| 13. | Pattern of skin thickness progression and clinical correlation in Thai scleroderma patients. | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 |
International journal of rheumatic diseases 5 (15), pp. e90-5 |
|
| 14. | Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients. | Kunyakham, W Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2012 |
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 2 (30), pp. 152-7 |
|
| 15. | Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis. | Netwijitpan, S Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2013 |
Clinical rheumatology 3 (32), pp. 361-7 |
|
| 16. | Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database. | Foocharoen, C Thavornpitak, Y Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2013 |
International journal of rheumatic diseases 1 (16), pp. 41-6 |
|
| 17. | Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients. | Kitchongcharoenying, P Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2013 |
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 4 (31), pp. 314-9 |
|
| 18. | Features and outcomes of hospitalized Thai patients with pyogenic arthritis: analysis from the nationwide hospital database. | Mahakkanukrauh, A Thavornpitak, Y Foocharoen, C Suwannaroj, S Nanagara, R |
2013 |
International journal of rheumatic diseases 4 (16), pp. 387-91 |
|
| 19. | Clinical characteristics and mortality in systemic sclerosis: a comparison between early- and late-referred diseases. | Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2014 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1 (97), pp. 28-35 |
|
| 20. | Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary? | Foocharoen, C Mahakkanukrauh, A Pussadhamma, B Netwijitpan, S Suwannaroj, S Nanagara, R |
2014 |
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 5 (20), pp. 268-74 |
|
| 21. | Prevalence and causes of loss to follow-up among patients with systemic sclerosis. | Foocharoen, C Yenrom, P Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2014 |
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 8 (20), pp. 456 |
|
| 22. | Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report). | Foocharoen, C Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2015 |
Rheumatology (Oxford, England) 9 (54), pp. 1616-21 |
|
| 23. | Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma. | Foocharoen, C Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2016 |
International journal of rheumatic diseases 9 (19), pp. 913-923 |
|
| 24. | Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. | Foocharoen, C Suwannachat, P Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Nanagara, R , , , , , , , , |
2016 |
International journal of rheumatic diseases 3 (19), pp. 312-20 |
|
| 25. | Self-assessment of skin tightness severity by scleroderma patients. | Daungkum, K Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Thinkhamrop, B Nanagara, R |
2016 |
International journal of rheumatic diseases 10 (19), pp. 989-995 |
|
| 26. | Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma. | Suebmee, P Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Theerakulpisut, D Nanagara, R |
2016 |
The American journal of the medical sciences 2 (352), pp. 166-71 |
|
| 27. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial. | Foocharoen, C Chunlertrith, K Mairiang, P Mahakkanukrauh, A Suwannaroj, S Namvijit, S Wantha, O Nanagara, R |
2017 |
Rheumatology (Oxford, England) 2 (56), pp. 214-222 |
|
| 28. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population. | Tempark, T Satapornpong, P Rerknimitr, P Nakkam, N Saksit, N Wattanakrai, P Jantararoungtong, T Koomdee, N Mahakkanukrauh, A Tassaneeyakul, W Suttisai, S Pratoomwun, J Klaewsongkram, J Rerkpattanapipat, T Sukasem, C |
2017 |
Pharmacogenetics and genomics 12 (27), pp. 429-437 |
|
| 29. | Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. | Foocharoen, C Watcharenwong, P Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2017 |
International journal of rheumatic diseases 10 (20), pp. 1572-1581 |
|
| 30. | 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. | Louthrenoo, W Kasitanon, N Katchamart, W Aiewruengsurat, D Chevaisrakul, P Chiowchanwisawakit, P Dechanuwong, P Hanvivadhanakul, P Mahakkanukrauh, A Manavathongchai, S Muangchan, C Narongroeknawin, P Phumethum, V Siripaitoon, B Suesuwan, A Suwannaroj, S Uea-Areewongsa, P Ukritchon, S Asavatanabodee, P Koolvisoot, A Nanagara, R Totemchokchyakarn, K Nuntirooj, K Kitumnuaypong, T |
2017 |
International journal of rheumatic diseases 9 (20), pp. 1166-1184 |
|
| 31. | Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. | , , , Katchamart, W Narongroeknawin, P Chevaisrakul, P Dechanuwong, P Mahakkanukrauh, A Kasitanon, N Pakchotanon, R Sumethkul, K Ueareewongsa, P Ukritchon, S Bhurihirun, T Duangkum, K Intapiboon, P Intongkam, S Jangsombatsiri, W Jatuworapruk, K Kositpesat, N Leungroongroj, P Lomarat, W Petcharat, C Sittivutworapant, S Suebmee, P Tantayakom, P Tipsing, W Asavatanabodee, P Chiowchanwisawakit, P Foocharoen, C Koolvisoot, A Louthrenoo, W Siripaitoon, B Totemchokchyakarn, K Kitumnuaypong, T , |
2017 |
International journal of rheumatic diseases 9 (20), pp. 1142-1165 |
|
| 32. | Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry. | Narongroeknawin, P Chevaisrakul, P Kasitanon, N Kitumnuaypong, T Mahakkanukrauh, A Siripaitoon, B Katchamart, W , |
2018 |
International journal of rheumatic diseases 1 (21), pp. 170-178 |
|
| 33. | Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis. | Apipattarakul, R Foocharoen, C Netwijitpan, S Mahakkanukrauh, A Suwannaroj, S Limpawattana, P Nanagara, R |
2018 |
Clinical and experimental rheumatology 4 (36), pp. 76-81 |
|
| 34. | Efficacy of Adjunctive Hyperbaric Oxygen Therapy in Osteoradionecrosis. | Jenwitheesuk, K Mahakkanukrauh, A Punjaruk, W Jenwitheesuk, K Chowchuen, B Jinaporntham, S Uraiwan, K Limrattanapimpa, P |
2018 |
BioResearch open access 1 (7), pp. 145-149 |
|
| 35. | Effect of season on clinical outcomes of Thai systemic sclerosis: analysis of the Thai national healthcare database. | Foocharoen, C Peansukwech, U Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S |
2019 |
Modern rheumatology (), pp. 1-19 |
|
| 36. | Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study. | Tipparot, T Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Nanagara, R Pussadhamma, B Chaosuwannakit, N |
2019 |
International journal of rheumatic diseases 12 (22), pp. 2125-2133 |
|
| 37. | Radiation ulcer treatment with hyperbaric oxygen therapy and haemoglobin spray: case report and literature review. | Winaikosol, K Punyavong, P Jenwitheesuk, K Surakunprapha, P Mahakkanukrauh, A |
2020 |
Journal of wound care 8 (29), pp. 452-456 |
|
| 38. | Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study. | Foocharoen, C Chunlertrith, K Mairiang, P Mahakkanukrauh, A Suwannaroj, S Namvijit, S Wantha, O Nanagara, R |
2020 |
Scientific reports 1 (10), pp. 769 |
|
| 39. | Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis. | Wongjirattikarn, R Chaowattanapanit, S Choonhakarn, C So-Ngern, A Mahakkanukrauh, A Foocharoen, C |
2020 |
Case reports in dermatology 1 (12), pp. 57-63 |
|
| 40. | Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study. | Foocharoen, C Peansukwech, U Mahakkanukrauh, A Suwannaroj, S Pongkulkiat, P Khamphiw, P Nanagara, R |
2020 |
International journal of rheumatic diseases 7 (23), pp. 945-957 |
|
| 41. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis. | Krikeerati, T Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2020 |
Modern rheumatology (), pp. 1-20 |
|
| 42. | Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis. | Jutiviboonsuk, A Salang, L Eamudomkarn, N Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2021 |
Clinical rheumatology 6 (40), pp. 2267-2275 |
|
| 43. | Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. | Satapornpong, P Pratoomwun, J Rerknimitr, P Klaewsongkram, J Nakkam, N Rungrotmongkol, T Konyoung, P Saksit, N Mahakkanukrauh, A Amornpinyo, W Khunarkornsiri, U Tempark, T Wantavornprasert, K Jinda, P Koomdee, N Jantararoungtong, T Rerkpattanapipat, T Wang, CW Naisbitt, D Tassaneeyakul, W Ariyachaipanich, M Roonghiranwat, T Pirmohamed, M Chung, WH Sukasem, C |
2021 |
Frontiers in immunology (12), pp. 661135 |
|
| 44. | The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients. | Paolee, Y Foocharoen, C Charoensri, S Mayxay, M Mahakkanukrauh, A Suwannaroj, S Nanagara, R |
2021 |
Scientific reports 1 (11), pp. 14902 |
|
| 45. | Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study). | Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2021 |
The American journal of the medical sciences 6 (362), pp. 570-577 |
|
| 46. | Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis. | Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2021 |
Archives of medical science : AMS 6 (17), pp. 1696-1705 |
|
| 47. | Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease. | Arunsurat, I Mahakkanukrauh, A Foocharoen, C Suwannaroj, S Nanagara, R , |
2021 |
Clinical rheumatology 1 (40), pp. 205-211 |
|
| 48. | Is Adjunctive Hyperbaric Oxygen Treatment Alone or with Surgery the Proper Management for Active and Persistent Osteoradionecrosis? | Jenwitheesuk, K Mahakkanukrauh, A Punjaruk, W Vatanasapt, P Jenwitheesuk, K Surakunprapha, P Jinaporntham, S Uraiwan, K Limrattanapimpa, P |
2021 |
Advances in skin & wound care 2 (34), pp. 1-4 |
|
| 49. | Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database. | Foocharoen, C Peansukwech, U Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S |
2021 |
Scientific reports 1 (11), pp. 7983 |
|
| 50. | Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis. | Chuealee, W Foocharoen, C Mahakkanukrauh, A Suwannaroj, S Pongchaiyakul, C Nanagara, R |
2021 |
Scientific reports 1 (11), pp. 9424 |
|
| 51. | Skin model for improving the reliability of the modified Rodnan skin score for systemic sclerosis. | Pongkulkiat, P Thinkhamrop, B Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2022 |
BMC rheumatology 1 (6), pp. 33 |
|
| 52. | Skin thickness affects the result of tuberculin skin test in systemic sclerosis. | So-Ngern, A Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2022 |
BMC rheumatology 1 (6), pp. 48 |
|
| 53. | Prevalence of moderate to severe lower urinary tract symptoms in systemic sclerosis. | Rompsaithong, U Sirithanaphol, W Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2022 |
Rheumatology (Oxford, England) 10 (61), pp. 4016-4023 |
|
| 54. | Prevalence and clinical associations with primary hypogonadism in male systemic sclerosis. | Thepwiwatjit, S Charoensri, S Sirithanaphol, W Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2022 |
Journal of scleroderma and related disorders 3 (7), pp. 234-242 |
|
| 55. | Development and validation of machine learning for early mortality in systemic sclerosis. | Foocharoen, C Thinkhamrop, W Chaichaya, N Mahakkanukrauh, A Suwannaroj, S Thinkhamrop, B |
2022 |
Scientific reports 1 (12), pp. 17178 |
|
| 56. | Predictors for Dry Eye Diseases in Patients with Systemic Sclerosis. | Laovirojjanakul, W Yospaiboon, Y Anutarapongpan, O Mahakkanukrauh, A Suwannaroj, S Nanagara, R Foocharoen, C |
2022 |
Clinical ophthalmology (Auckland, N.Z.) (16), pp. 3447-3455 |
|
| 57. | Prevalence and clinical association of sarcopenia among Thai patients with systemic sclerosis. | Sangaroon, A Foocharoen, C Theerakulpisut, D Srichompoo, K Mahakkanukrauh, A Suwannaroj, S Seerasaporn, P Pongchaiyakul, C |
2022 |
Scientific reports 1 (12), pp. 18198 |
|
| 58. | Prevalence of peripheral eosinophilia and clinical associations in systemic sclerosis patients. | Foocharoen, C Mahakkanukrauh, A Maleewong, P Maleewong, W Jumnainsong, A Pongkulkiat, P Teawtrakul, N Suwannaroj, S Nanagara, R |
2022 |
The American journal of the medical sciences 6 (363), pp. 519-525 |
|
| 59. | Safety and effectiveness of intravenous CT-P13 in inflammatory arthritis: post-marketing surveillance study in Thailand. | Mahakkanukrauh, A Chaiamnuay, S Koolvisoot, A Kitamnuayphong, T Manavathongchai, S Osiri, M Louthrenoo, W Uea-Areewongsa, P Ahn, K Jung, N Kim, M Lee, S Kim, H Kim, S |
2023 |
Immunotherapy 14 (15), pp. 1143-1155 |
|
| 60. | Management review of scleroderma renal crisis: An update with practical pointers. | Foocharoen, C Tonsawan, P Pongkulkiat, P Anutrakulchai, S Mahakkanukrauh, A Suwannaroj, S |
2023 |
Modern rheumatology 1 (33), pp. 12-20 |
|
| 61. | Fingerprint comparison between before disease onset and after systemic sclerosis diagnosis: a monocentric cross-sectional study. | Sriwong, WT Srisangwarn, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 |
Clinical rheumatology 1 (42), pp. 117-124 |
|
| 62. | Prevalence of erectile dysfunction in Thai scleroderma patients and associated factors. | Sirithanaphol, W Mahakkanukrauh, A Nanagara, R Foocharoen, C |
2023 |
PloS one 1 (18), pp. e0279087 |
|
| 63. | Incidence and prevalence of systemic sclerosis in Thailand in year 2017-2020: a database from the Ministry of Public Health. | Foocharoen, C Ngamjarus, C Pattanittum, P Suwannaroj, S Pongkulkiat, P Onchan, T Wattanasukchai, L Chaiyarit, J Mahakkanukrauh, A |
2023 |
Clinical rheumatology (), pp. 1-8 |
|
| 64. | Attitudes and factors affecting decision-making regarding COVID-19 vaccination among autoimmune rheumatic disease patients. | Wantha, O Mahakkanukrauh, A Tuydaung, K Donsrichan, W Yingyaun, K Kaewmeun, S Suwannaroj, S Foocharoen, C |
2023 |
International journal of rheumatic diseases 4 (26), pp. 751-758 |
|
| 65. | Sleep quality and clinical association with sleep disturbance in systemic sclerosis. | Wongthawa, N So-Gnern, A Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 |
BMC rheumatology 1 (7), pp. 21 |
|
| 66. | Cost-effectiveness of alginic acid in combination with proton pump inhibitor for the treatment of gastroesophageal reflux disease in systemic sclerosis patients. | Foocharoen, C Kingkaew, P Teerawattananon, Y Mahakkanukrauh, A Suwannaroj, S Manasirisuk, W Chaiyarit, J Sangchan, A |
2023 |
International journal of rheumatic diseases 10 (26), pp. 2037-2046 |
|
| 67. | Incidence and Prevalence of Septic Arthritis in Thailand: A Database from the Ministry of Public Health. | Foocharoen, T Onchan, T Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2023 |
Open access rheumatology : research and reviews (15), pp. 213-222 |
|
| 68. | Prevalence of low trabecular bone score and its association with disease severity and activity in patients with axial spondyloarthritis. | Saisirivechakun, P Mahakkanukrauh, A Pongchaiyakul, C Boonya-Ussadorn, T Narongroeknawin, P Pakchotanon, R Assavatanabodee, P Chaiamnuay, S |
2023 |
Scientific reports 1 (13), pp. 16258 |
|
| 69. | Incidence of Systemic Vasculitis and Clinical Outcomes in Systemic Sclerosis: 2-Years Follow-Up of Asymptomatic Positive for Anti-Neutrophilic Cytoplasmic Antibody. | Suwannamajo, R Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2024 |
Clinical, cosmetic and investigational dermatology (17), pp. 301-309 |
|
| 70. | Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study. | Rattanakaemakorn, P Chevaisrakul, P Wongpraparut, C Chiowchanwisawakit, P Tovanabutra, N Tantiwong, P Amornpinyo, W Chakkavittumrong, P Hanvivadhanakul, P Chaiamnuay, S Laodheerasiri, S Pattamadilok, B Choonhakarn, C Mahakkanukrauh, A Aiewruengsurat, D Sangmala, S Pretikul, N Sumethkul, K Satpanich, P Boonsiri, M Sangob, N Asawanonda, P , |
2024 |
Dermatology and therapy 12 (14), pp. 3229-3241 |
|
| 71. | Incidence and prevalence of idiopathic inflammatory myopathies in Thailand from the Ministry of Public Health data analysis. | Onchan, T Foocharoen, C Pongkulkiat, P Suwannaroj, S Mahakkanukrauh, A |
2024 |
Scientific reports 1 (14), pp. 20646 |
|
| 72. | The incidence and prevalence of ankylosing spondylitis in Thailand using ministry of public health database. | Mahakkanukrauh, A Suwannaroj, S Pongkulkiat, P Onchan, T Foocharoen, C |
2024 |
Scientific reports 1 (14), pp. 16981 |
|
| 73. | Clinical courses and predictors of left ventricular systolic dysfunction in systemic sclerosis: A cohort study. | Werakiat, J Pussadhamma, B Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2024 |
Rheumatology and immunology research 2 (5), pp. 107-116 |
|
| 74. | Outcomes of myocarditis in systemic sclerosis: A 3-year follow-up. | Mahakkanukrauh, A Foocharoen, C Chaosuwannakit, N Suwannaroj, S Pongkulkiat, P Onchan, T Pussadhamma, B |
2024 |
Rheumatology and immunology research 2 (5), pp. 117-125 |
|
| 75. | Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients. | Mulalin, K Mahakkanukrauh, A Suwannaroj, S Pongkulkiat, P Onchan, T Kasa, S Foocharoen, C |
2024 |
Scientific reports 1 (14), pp. 10354 |
|
| 76. | Clinical outcomes and associated factors with mortality in systemic sclerosis patients with sarcopenia. | Hongkanjanapong, S Pongkulkiat, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2025 |
The American journal of the medical sciences 1 (369), pp. 35-43 |
|
| 77. | Validation and cross-cultural adaptation of the Thai version of the Systemic Sclerosis Health Assessment Questionnaire. | Ruangnopparut, R Osiri, M Suwannaroj, S Mahakkanukrauh, A Pongkulkiat, P Onchan, T Foocharoen, C |
2025 |
Clinical rheumatology 8 (44), pp. 3235-3243 |
|
| 78. | Case Report: Chalk-Like Synovial Fluid and Calcified Synovium in Systemic Sclerosis Overlapping With Rheumatoid Arthritis Stabilized by Rituximab. | Khounthep, A Thummaroj, P Mahakkanukrauh, A Suwannaroj, S Foocharoen, C |
2025 |
International journal of rheumatic diseases 7 (28), pp. e70352 |
|
| 79. | Incidence and prevalence of rheumatoid arthritis in Thailand based on National administrative health data and a comprehensive literature review. | Senaveenin, N Mahakkanukrauh, A Foocharoen, C Suwannaroj, S Onchan, T Pongkulkiat, P |
2025 |
Scientific reports 1 (15), pp. 20665 |
|
| 80. | Evaluation of a self-screening tool and patient alert cards to help patients identify and manage severe adverse drug reactions. | Srisuriyachanchai, W Foocharoen, C Mahakkanukrauh, A Cox, AR Jarernsiripornkul, N |
2025 |
International journal of clinical pharmacy 3 (47), pp. 726-736 |
|
| 81. | Efficacy and safety of 2% isosorbide cream in systemic sclerosis patients with digital ulcers and Raynaud's phenomenon. | Namvijit, S Foocharoen, C Suwannaroj, S Pongkulkait, P Onchan, T Mahakkanukrauh, A |
2025 |
Rheumatology and immunology research 1 (6), pp. 52-58 |
|
| 82. | Epidemiology of systemic sclerosis in the Asia-Pacific region: a systematic review and meta-analysis. | Mahakkanukrauh, A Ngamjarus, C Pattanittum, P Suwannaroj, S Pongkulkiat, P Onchan, T Foocharoen, C |
2025 |
Annals of medicine 1 (57), pp. 2479238 |
|
| 83. | Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia. | Wanitpongpun, C Teawtrakul, N Mahakkanukrauh, A Siritunyaporn, S Sirijerachai, C Chansung, K |
Clinical and experimental rheumatology 6 (30), pp. 825-9 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | ||||||
| 1. | Long term treatment outcome of Salmonella septic arthritis. | R Nanagara S Suwannaroj A Mahakkanukrauh HR Schumacher |
2001 |
ARTHRITIS AND RHEUMATISM 9.0 (44.0), pp. S348-S348 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 2. | Systemic sclerosis (SSC) in the northeastern Thais: A clinical data in 506 patients | S Suwannaroj A Mahakkanukrauh R Nanagara |
2004 |
ANNALS OF THE RHEUMATIC DISEASES (63.0), pp. 338.0-338.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3. | Outward migration of Gnathostoma spinigerum in interferon alpha treated hepatitis C patient | A Sangchan K Sawanyawisuth PM Intapan A Mahakkanukrauh |
2006 |
PARASITOLOGY INTERNATIONAL 1.0 (55.0), pp. 31.0-32.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 4. | CLINICAL FEATURES OF TUBERCULOUS SEPTIC ARTHRITIS IN KHON KAEN, THAILAND A 10-YEAR RETROSPECTIVE STUDY | Chingching Foocharoen Ratanavadee Nanagara Thanit Foocharoen Pirun Mootsikapun Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2010 |
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH 6.0 (41.0), pp. 1438.0-1446.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 5. | Clinical features and disease outcomes of undifferentiated arthritis in Thailand | Chingching Foocharoen Ratanavadee Nanagara Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2011 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 3.0 (14.0), pp. E14-E21 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 6. | Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand | Chingching Foocharoen Ratanavadee Nanagara Songsak Kiatchoosakun Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2011 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 3.0 (14.0), pp. 282.0-289.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 7. | Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients | Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2011 |
CLINICAL RHEUMATOLOGY 9.0 (30.0), pp. 1235.0-1240.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 8. | Survival rate among Thai systemic lupus erythematosus patients in the era of aggressive treatment | Chingching Foocharoen Ratanavadee Nanagara Siraphop Suwannaroj Ajanee Mahakkanukrauh |
2011 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 4.0 (14.0), pp. 353.0-360.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 9. | SYNOVIAL FLUID ADENOSINE DEAMINASE ACTIVITY TO DIAGNOSE TUBERCULOUS SEPTIC ARTHRITIS | Chingching Foocharoen Chatchawal Sarntipipattana Thanit Foocharoen Ajanee Mahakkanukrauh Anucha Paupairoj Yaovalak Teerajetgul Ratanavadee Nanagara |
2011 |
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH 2.0 (42.0), pp. 331.0-337.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 10. | Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia | C. Wanitpongpun N. Teawtrakul A. Mahakkanukrauh S. Siritunyaporn C. Sirijerachai K. Chansung |
2012 |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 6.0 (30.0), pp. 825.0-829.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 11. | INCIDENCE RATE AND CAUSES OF INFECTION IN THAI SSc PATIENTS | C. Foocharoen Y. Siriphanon A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 |
RHEUMATOLOGY (51.0), pp. 95.0-96.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 12. | Incidence rate and causes of infection in Thai systemic sclerosis patients | Chingching Foocharoen Yada Siriphannon Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2012 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 3.0 (15.0), pp. 277.0-283.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 13. | PATTERN OF SKIN THICKNESS PROGRESSION AND CLINICAL CORRELATION IN THAI SCLERODERMA PATIENTS | C. Foocharoen A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 |
RHEUMATOLOGY (51.0), pp. 94.0-95.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 14. | Pattern of skin thickness progression and clinical correlation in Thai scleroderma patients | Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2012 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 5.0 (15.0), pp. E90-E95 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 15. | Prevalence and risk factor for symptomatic avascular necrosis development in Thai systemic lupus erythematosus patients | Wichak Kunyakham Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2012 |
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY 2.0 (30.0), pp. 152.0-157.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 16. | PROGNOSTIC FACTORS OF MORTALITY AND 2-YEAR SURVIVAL ANALYSIS OF SSc WITH PULMONARY ARTERIAL HYPERTENSION IN THAILAND | C. Foocharoen R. Nanagara S. Kiatchoosakun S. Suwannaroj A. Mahakkanukrauh |
2012 |
RHEUMATOLOGY (51.0), pp. 95.0-95.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 17. | SPONTANEOUS SKIN REGRESSION AND PREDICTORS OF SKIN REGRESSION IN THAI SCLERODERMA PATIENTS | C. Foocharoen A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2012 |
RHEUMATOLOGY (51.0), pp. 93.0-94.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 18. | Admission rate and characteristics of hospitalized systemic connective tissue disorders: analysis from a nationwide Thailand healthcare database | Chingching Foocharoen Yupa Thavornpitak Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2013 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 1.0 (16.0), pp. 41.0-46.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 19. | Features and outcomes of hospitalized Thai patients with pyogenic arthritis: Analysis from the nationwide hospital database | Ajanee Mahakkanukrauh Yupa Thavornpitak Chingching Foocharoen Siraphop Suwannaroj Ratanavadee Nanagara |
2013 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 4.0 (16.0), pp. 387.0-391.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 20. | Indications for hospitalization and in-hospital mortality in Thai systemic sclerosis | Sittichai Netwijitpan Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2013 |
CLINICAL RHEUMATOLOGY 3.0 (32.0), pp. 361.0-367.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 21. | Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients | Patipat Kitchongcharoenying Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2013 |
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY 4.0 (31.0), pp. 314.0-319.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 22. | ASYMPTOMATIC CARDIAC INVOLVEMENT IN THAI SYSTEMIC SCLEROSIS: PREVALENCE AND CLINICAL CORRELATION | C. Foocharoen B. Pussadhamma A. Mahakkanukrauh S. Suwannaroj R. Nanagara |
2014 |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2.0 (32.0), pp. S93-S93 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 23. | Incidence of Pulmonary Hypertension in Patients With Systemic Sclerosis and No Pulmonary Symptoms: Is Annual Echocardiographic Screening Necessary? | Chingching Foocharoen Ajanee Mahakkanukrauh Burabha Pussadhamma Sittichai Netwijitpan Siraphop Suwannaroj Ratanavadee Nanagara |
2014 |
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 5.0 (20.0), pp. 268.0-274.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 24. | Prevalence and Causes of Loss to Follow-up Among Patients With Systemic Sclerosis | Chingching Foocharoen Patinut Yenrom Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2014 |
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 8.0 (20.0), pp. 456.0-456.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 25. | Asymptomatic cardiac involvement in Thai systemic sclerosis: prevalence and clinical correlations with non-cardiac manifestations (preliminary report) | Chingching Foocharoen Burabha Pussadhamma Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2015 |
RHEUMATOLOGY 9.0 (54.0), pp. 1616.0-1621.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 26. | Causes and prevalence of inadequate pulmonary function testing among patients with systemic sclerosis | Pichaporn Sumphao-Ngern Chingching Foocharoen Watchara Boonsawat Ajanee Mahakkanukrauh Siraphop Suwannaroj Uraiwan Sae-Oue Sittichai Netwijitpan Ratanavadee Nanagara |
2015 |
ARCHIVES OF MEDICAL SCIENCE 6.0 (11.0), pp. 1255.0-1260.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 27. | Drug Survival and Reasons for Discontinuation of Biological Disease Modifying Antirheumatic Drug in Thai Patients with Rheumatoid Arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization (RDPA) Register | Pongthorn Narongroeknawin Wanruchada Katchamart Parawee Suwannalai Nuntana Kasitanon Tasanee Kitumnuaypong Ajanee Mahakkanukrauh Boonjing Siripaitoon |
2015 |
ARTHRITIS & RHEUMATOLOGY (67.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 28. | Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma | Chingching Foocharoen Sittichai Netwijitpan Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2016 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 9.0 (19.0), pp. 913.0-923.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 29. | Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I | Chingching Foocharoen Prangsuporn Suwannachat Sittichai Netwijitpan Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2016 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 3.0 (19.0), pp. 312.0-320.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 30. | Correlation of Glomerular Filtration Rate Between Renal Scan and Estimation Equation for Patients With Scleroderma | Patcharawan Suebmee Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Daris Theerakulpisut Ratanavadee Nanagara |
2016 |
AMERICAN JOURNAL OF THE MEDICAL SCIENCES 2.0 (352.0), pp. 166.0-171.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 31. | Self-assessment of skin tightness severity by scleroderma patients | Kittikorn Daungkum Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Bandit Thinkhamrop Ratanavadee Nanagara |
2016 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 10.0 (19.0), pp. 989.0-995.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 32. | 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis | Worawit Louthrenoo Nuntana Kasitanon Wanruchada Katchamart Duangkamol Aiewruengsurat Parawee Chevaisrakul Praveena Chiowchanwisawakit Pornchai Dechanuwong Punchong Hanvivadhanakul Ajanee Mahakkanukrauh Siriporn Manavathongchai Chayawee Muangchan Pongthorn Narongroeknawin Veerapong Phumethum Boonjing Siripaitoon Anawat Suesuwan Siraphop Suwannaroj Parichat Uea-Areewongsa Sittichai Ukritchon Paijit Asavatanabodee Ajchara Koolvisoot Ratanavadee Nanagara Kitti Totemchokchyakarn Kanokrut Nuntirooj Tasanee Kitumnuaypong |
2017 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 9.0 (20.0), pp. 1166.0-1184.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 33. | Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13:01 allele in the Thai population | Therdpong Tempark Patompong Satapornpong Pawinee Rerknimitr Nontaya Nakkam Niwat Saksit Penpun Wattanakrai Thawinee Jantararoungtong Napatrupron Koomdee Ajanee Mahakkanukrauh Wichittra Tassaneeyakul Sumitra Suttisai Jirawat Pratoomwun Jettanong Klaewsongkram Ticha Rerkpattanapipat Chonlaphat Sukasem |
2017 |
PHARMACOGENETICS AND GENOMICS 12.0 (27.0), pp. 429.0-437.0 |
80 | 0 | 0 | 0 | 0 | 0 | 80 | |
| 34. | Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial | Chingching Foocharoen Kitti Chunlertrith Pisaln Mairiang Ajanee Mahakkanukrauh Siraphop Suwannaroj Suwassa Namvijit Orathai Wantha Ratanavadee Nanagara |
2017 |
RHEUMATOLOGY 2.0 (56.0), pp. 214.0-222.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 35. | Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association | Wanruchada Katchamart Pongthorn Narongroeknawin Parawee Chevaisrakul Pornchai Dechanuwong Ajanee Mahakkanukrauh Nuntana Kasitanon Rattapol Pakchotanon Kittiwan Sumethkul Parichat Ueareewongsa Sittichai Ukritchon Thitirat Bhurihirun Kittikorn Duangkum Porntip Intapiboon Samanan Intongkam Wimol Jangsombatsiri Kanon Jatuworapruk Naravadee Kositpesat Pawinee Leungroongroj Wiyanoot Lomarat Chonachan Petcharat Siriluck Sittivutworapant Patcharawan Suebmee Pongchirat Tantayakom Worakan Tipsing Paijit Asavatanabodee Praveena Chiowchanwisawakit Chingching Foocharoen Ajchara Koolvisoot Worawit Louthrenoo Boonjing Siripaitoon Kitti Totemchokchyakarn Tasanee Kitumnuaypong |
2017 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 9.0 (20.0), pp. 1142.0-1165.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 36. | Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais | Chingching Foocharoen Piyakarn Watcharenwong Sittichai Netwijitpan Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2017 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 10.0 (20.0), pp. 1572.0-1581.0 |
30 | 0 | 0 | 0 | 0 | 0 | 30 | |
| 37. | Clinical characteristics and mortality rate of Thai elderly-onset systemic sclerosis | R. Apipattarakul C. Foocharoen S. Netwijitpan A. Mahakkanukrauh S. Suwannaroj P. Limpawattana R. Nanagara |
2018 |
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 4.0 (36.0), pp. S76-S81 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 38. | Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry | Pongthorn Narongroeknawin Parawee Chevaisrakul Nuntana Kasitanon Tasanee Kitumnuaypong Ajanee Mahakkanukrauh Boonjing Siripaitoon Wanruchada Katchamart |
2018 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 1.0 (21.0), pp. 169.0-177.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 39. | Efficacy of Adjunctive Hyperbaric Oxygen Therapy in Osteoradionecrosis | Kamonwan Jenwitheesuk Ajanee Mahakkanukrauh Wiyada Punjaruk Kriangsak Jenwitheesuk Bowornsilp Chowchuen Suthin Jinaporntham Krittinant Uraiwan Phasuk Limrattanapimpa |
2018 |
BIORESEARCH OPEN ACCESS 1.0 (7.0), pp. 145.0-149.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 40. | Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study | Thapanee Tipparot Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Burabha Pussadhamma Narumol Chaosuwannakit |
2019 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 12.0 (22.0), pp. 2125.0-2133.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 41. | PREVALENCE OF PERIPHERAL EOSINOPHILIA AND CLINICAL ASSOCIATIONS IN THAI SYSTEMIC SCLEROSIS PATIENTS | Chingching Foocharoen Patnarin Kongkulkiat Ajanee Mahakkanukrauh Pewpan Maleewong Intapan Wanchai Maleewong Amonrat Jumnainsong Nattiya Teawtrakul Siraphop Suwannaroj Ratanavadee Nanagara |
2019 |
ANNALS OF THE RHEUMATIC DISEASES (78.0), pp. 1226.0-1227.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 42. | TUBERCULIN SKIN TEST FOR DETECTION OF TUBERCULOSIS IN SYSTEMIC SCLEROSIS | Apichat So-Ngern Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2019 |
ANNALS OF THE RHEUMATIC DISEASES (78.0), pp. 855.0-856.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 43. | Acral Cutaneous Ulcerations and Livedo Reticularis with Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Classical Dermatomyositis | Rachot Wongjirattikarn Suteeraporn Chaowattanapanit Charoen Choonhakarn Apichart So-ngern Ajanee Mahakkanukrauh Chingching Foocharoen |
2020 |
CASE REPORTS IN DERMATOLOGY 1.0 (12.0), pp. 57.0-63.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 44. | Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: A cohort study | Chingching Foocharoen Udomlack Peansukwech Ajanee Mahakkanukrauh Siraphop Suwannaroj Patnarin Pongkulkiat Penpiriya Khamphiw Ratanavadee Nanagara |
2020 |
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES 7.0 (23.0), pp. 945.0-957.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 45. | Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study | Burabha Pussadhamma Thapanee Tipparot Naruemol Chaosuwannakit Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2020 |
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2020.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 46. | Effect of season on clinical outcomes of Thai systemic sclerosis: Analysis of the Thai national healthcare database | Chingching Foocharoen Udomlack Peansukwech Patnarin Pongkulkiat Ajanee Mahakkanukrauh Siraphop Suwannaroj |
2020 |
MODERN RHEUMATOLOGY 6.0 (30.0), pp. 1025.0-1032.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 47. | Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study | Chingching Foocharoen Kitti Chunlertrith Pisaln Mairiang Ajanee Mahakkanukrauh Siraphop Suwannaroj Suwassa Namvijit Orathai Wantha Ratanavadee Nanagara |
2020 |
SCIENTIFIC REPORTS 1.0 (10.0), pp. |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 48. | Radiation ulcer treatment with hyperbaric oxygen therapy and haemoglobin spray: case report and literature review | Kengkart Winaikosol Pattama Punyavong Kamonwan Jenwitheesuk Palakorn Surakunprapha Ajanee Mahakkanukrauh |
2020 |
JOURNAL OF WOUND CARE 8.0 (29.0), pp. 452.0-456.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 49. | Aerosol components associated with hospital mortality in systemic sclerosis: an analysis from a nationwide Thailand healthcare database | Chingching Foocharoen Udomlack Peansukwech Patnarin Pongkulkiat Ajanee Mahakkanukrauh Siraphop Suwannaroj |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 50. | Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis | Thanachit Krikeerati Burabha Pussadhamma Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2021 |
MODERN RHEUMATOLOGY 3.0 (31.0), pp. 649.0-656.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 51. | Clinical Outcomes of Asymptomatic Cardiac Involvement in Systemic Sclerosis Patients After a 2-Year Follow-Up (Extended Study) | Burabha Pussadhamma Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2021 |
AMERICAN JOURNAL OF THE MEDICAL SCIENCES 6.0 (362.0), pp. 570.0-577.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 52. | HLA-B*13:01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients | Patompong Satapornpong Jirawat Pratoomwun Pawinee Rerknimitr Jettanong Klaewsongkram Nontaya Nakkam Thanyada Rungrotmongkol Parinya Konyoung Niwat Saksit Ajanee Mahakkanukrauh Warayuwadee Amornpinyo Usanee Khunarkornsiri Therdpong Tempark Kittipong Wantavornprasert Pimonpan Jinda Napatrupron Koomdee Thawinee Jantararoungtong Ticha Rerkpattanapipat Chuang-Wei Wang Dean Naisbitt Wichittra Tassaneeyakul Manasalak Ariyachaipanich Thapana Roonghiranwat Munir Pirmohamed Wen-Hung Chung Chonlaphat Sukasem |
2021 |
FRONTIERS IN IMMUNOLOGY (12.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 53. | Is Adjunctive Hyperbaric Oxygen Treatment Alone or with Surgery the Proper Management for Active and Persistent Osteoradionecrosis? | Kamonwan Jenwitheesuk Ajanee Mahakkanukrauh Wiyada Punjaruk Patravoot Vatanasapt Kriangsak Jenwitheesuk Palakorn Surakunprapha Suthin Jinaporntham Krittinant Uraiwan Phasuk Limrattanapimpa |
2021 |
ADVANCES IN SKIN & WOUND CARE 2.0 (34.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 54. | Outcome of pulse oral cyclophosphamide therapy in scleroderma interstitial lung disease | Itthiphat Arunsurat Ajanee Mahakkanukrauh Chingching Foocharoen Siraphop Suwannaroj Ratanavadee Nanagara |
2021 |
CLINICAL RHEUMATOLOGY 1.0 (40.0), pp. 205.0-211.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 55. | Prevalence and clinical association of the presence of anti-neutrophilic cytoplasmic antibody in systemic sclerosis | Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara Chingching Foocharoen |
2021 |
ARCHIVES OF MEDICAL SCIENCE 6.0 (17.0), pp. 1696.0-1705.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 56. | Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis | Arporn Jutiviboonsuk Lingling Salang Nuntasiri Eamudomkarn Ajanee Mahakkanukrauh Siraphop Suwannaroj Chingching Foocharoen |
2021 |
CLINICAL RHEUMATOLOGY 6.0 (40.0), pp. 2267.0-2275.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 57. | Prevalence and predictive factors of osteoporosis in Thai systemic sclerosis | Wiriya Chuealee Chingching Foocharoen Ajanee Mahakkanukrauh Siraphop Suwannaroj Chatlert Pongchaiyakul Ratanavadee Nanagara |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 58. | The prevalence and clinical features associated of hypothyroidism among Thai systemic sclerosis patients | Yathao Paolee Chingching Foocharoen Suranut Charoensri Mayfong Mayxay Ajanee Mahakkanukrauh Siraphop Suwannaroj Ratanavadee Nanagara |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Discontinuation of Antimalarial in Systemic Lupus Erythematosus | Ajanee Mahakkanukrauh | 1999 |
Srinagarind Medical Journal (14 No 4), pp. 293-294 |
|
| 2. | Adverse Drug Reactions Monitoring to Disease Modifying Antirheumatic Drugs (DMARDs) by Patient Self Reports | Pichayanin Ongtrakoolaree Narumol Jarernsiripornkul Ausanee Uajariyaku Ajanee Mahakkanukrauh |
2013 |
Srinagarind Medical Journal (28 No 3), pp. 302-310 |
|
| 3. | The Association of HLA and Systemic Sclerosis (SSc) in the Northeastern Thais. | Ajanee Mahakkanukrauh Siraphob Suwannaroj Amornrat Romphruk Chintana Puapairoj Arunrat Romphruk Chanvit Leelayuwat Ratanavadee Nanagara |
2015 |
KKU Research Journal 4 (20), pp. 459-464 |
| Title | Authors | NRIIS type | Year | NRIIS Scholarship |
|---|